Literature DB >> 23148196

Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report.

Torsten Slesaczeck, Hartmut Paetzold, Thomas Nanning, Andreas Reichel, Andreas Barthel, Stefan Bornstein, Matthias Weck.   

Abstract

Entities:  

Year:  2012        PMID： 23148196      PMCID： PMC3474651          DOI： 10.1177/2042018812438213

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN： 2042-0188            Impact factor:   3.565


× No keyword cloud information.
  13 in total

Review 1.  Novel use of platelet-rich plasma to augment curative diabetic foot surgery.

Authors:  Christy L Scimeca; Manish Bharara; Timothy K Fisher; Heather Kimbriel; David G Armstrong
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers.

Authors:  Vickie R Driver; Jason Hanft; Carelyn P Fylling; Judy M Beriou
Journal:  Ostomy Wound Manage       Date:  2006-06       Impact factor: 2.629

Review 3.  Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.

Authors:  Akinfemi Ayobami Akingboye; Stephen Giddins; Philip Gamston; Arthur Tucker; Harshad Navsaria; Constantions Kyriakides
Journal:  J Extra Corpor Technol       Date:  2010-03

4.  The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel.

Authors:  Jean M de Leon; Vickie R Driver; Carelyn P Fylling; Marissa J Carter; Carol Anderson; Janice Wilson; Rita Michelle Dougherty; Denise Fuston; Donna Trigilia; Vicky Valenski; Laurie M Rappl
Journal:  Adv Skin Wound Care       Date:  2011-08       Impact factor: 2.347

5.  Antimicrobial peptides from human platelets.

Authors:  Yi-Quan Tang; Michael R Yeaman; Michael E Selsted
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Chronic wounds treated with a physiologically relevant concentration of platelet-rich plasma gel: a prospective case series.

Authors:  Robert G Frykberg; Vickie R Driver; Donna Carman; Brenda Lucero; Cathy Borris-Hale; Carelyn P Fylling; Laurie M Rappl; Peter A Clausen
Journal:  Ostomy Wound Manage       Date:  2010-06       Impact factor: 2.629

7.  Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: an in vitro study.

Authors:  T M Bielecki; T S Gazdzik; J Arendt; T Szczepanski; W Król; T Wielkoszynski
Journal:  J Bone Joint Surg Br       Date:  2007-03

Review 8.  Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review.

Authors:  Diana Lima Villela; Vera Lúcia C G Santos
Journal:  Growth Factors       Date:  2010-04       Impact factor: 2.511

Review 9.  Platelet-rich plasma: support for its use in wound healing.

Authors:  Kathleen M Lacci; Alan Dardik
Journal:  Yale J Biol Med       Date:  2010-03

Review 10.  Platelet rich concentrate: basic science and current clinical applications.

Authors:  Samir Mehta; J Tracy Watson
Journal:  J Orthop Trauma       Date:  2008-07       Impact factor: 2.512
View more
  4 in total

1.  Augmentation techniques for isolated meniscal tears.

Authors:  Samuel A Taylor; Scott A Rodeo
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

2.  Hepatocyte Growth Factor Effects on Mesenchymal Stem Cells Derived from Human Arteries: A Novel Strategy to Accelerate Vascular Ulcer Wound Healing.

Authors:  Sabrina Valente; Carmen Ciavarella; Emanuela Pasanisi; Francesca Ricci; Andrea Stella; Gianandrea Pasquinelli
Journal:  Stem Cells Int       Date:  2015-12-14       Impact factor: 5.443

3.  Autologous platelet-rich gel and continuous vacuum sealing drainage for the treatment of patients with diabetic foot ulcer: Study Protocol.

Authors:  Jie Xu; Qiao-Yun Wang; Wei Li
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

4.  Adjunct methods of the standard diabetic foot ulceration therapy.

Authors:  Dariusz Waniczek; Andrzej Kozowicz; Małgorzata Muc-Wierzgoń; Teresa Kokot; Elżbieta Swiętochowska; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.